For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7247
Key Points Covered in Ophthalmic Ultrasound Devices Market Survey:
- Market Estimates and Forecasts (2017-2032)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- COVID-19 Impact on Ophthalmic Ultrasound Devices Market and How to Navigate
- Recommendation on Key Winning Strategies
Market Segments Covered in Ophthalmic Ultrasound Devices Market Analysis
-
By Product Type
- B-Scan
- A-Scan
- Combined
- Pachymeter
- Ultrasound Bio Microscope
-
By Mobility
- Portable
- Standalone
-
By End Use
- Hospitals
- Ambulatory Surgery Centers
- Ophthalmology Clinics
- Others
-
By Region
- North America
- Latin America
- Europe
- APAC
- MEA
Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7247
Competitive Analysis
The leading players are focusing on growth strategies, such as innovations in the existing product, frequent product launches, and mergers& acquisitions. Some of the recent developments of key Ophthalmic Ultrasound Devices providers are as follows:
- In March 2019, Quantal medical received U.S. FDA approval for the launch of its product called ABSolu.
- In April 2019, Lantheus announced in April that it would combine its microbubble technology with Cerevast’s ocular ultrasound device for the treatment of retinal vascular occlusion. This could be an entryway for newer RVO technologies in the years ahead, which may increase the effective use of recently developed ophthalmic ultrasound systems. Cerevast’s investigational ocular ultrasound program is undergoing a Phase 2b clinical trial in the second quarter of 2019.
Similarly, recent developments related to companies offering Ophthalmic Ultrasound Devices have been tracked by the team at Fact.MR, which are available in the full report.
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7247
What are the insights about segment A-Scan?
The A-Scan segment is expected to register highest CAGR of 9.1%. One of the primary elements which is expected to encourage sector growth is the high use of A-scan equipment for pre-operative viewing of a detached retina in circumstances such as vitreous haemorrhage, peri-orbital trauma, or lens opacification. A-scan offers significant advantages in cataract procedures, resulting in considerable demand. Furthermore, A-scan employs the most up-to-date transducer and electronic technology in ophthalmic practises, ensuring high reliability and accuracy. As a result, the segment is likely to increase at a considerable rate in the coming years.
For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
